Vaccine and Treatment Evaluation Unit: Pertussis Vaccine Development

Abstract

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.

Key facts

NIH application ID

10489227

Project number

272201300023I-P00005-27200017-1

Recipient

VANDERBILT UNIVERSITY MEDICAL CENTER

Principal Investigator

Kathryn Margaret Edwards

Activity code

N01

Funding institute

NIH

Fiscal year

2021

Award amount

$14,174

Award type

—

Project period

2015-04-07 → 2021-12-31